Skyscraper with transparent glass facade from below

Stefano Madrigali/Getty Images

Leveraged Loans

Sponsored European loan issuance surges in Q1 despite modest buyout activity

A cross-border marquee deal from Opella enlivened an otherwise tepid start to the year for buyout funding in the European leveraged loan market.

Want to see more? Fill out the form below.

I agree to PitchBook’s privacy policy

A cross-border marquee deal from Opella enlivened an otherwise tepid start to the year for buyout funding in the European leveraged loan market.

Though running ahead of the first-quarter pace set in 2024 and 2023, the €6.1 billion of institutional and pro rata LBO loan supply in Q1 2025 fell short of other comparable Q1 periods. Looking back before the start of rate-hiking cycles among global central banks, first-quarter LBO loan issuance averaged €8.7 billion from 2018-2022. 

Institutional LBO loan volume totaled €4.21 billion in the latest quarter, while pro rata LBO loan issuance came in at €1.89 billion.



Jumbo deal
Buoying LBO loan supply, the jumbo deal backing Clayton Dubilier & Rice’s purchase of a stake in Sanofi SA’s consumer health division Opella cleared syndication at the end of March against a difficult market backdrop. The overall loan portion of the borrower's globally placed €7.45 billion debt package was downsized to €5.20 billion, from €5.45 billion.

Without Opella’s €1.75 billion term loan from the financing package and excluding the pro rata portion, Europe’s institutional loan issuance for buyouts in Q1 2025 would total €2.46 billion, down 66% from the comparable Q1 2022 total (€7.22 billion), before a rate-induced period of muted M&A supply set in. Ahead of this month’s extreme tariff-induced volatility, hopes were high that 2025 would bring a much-needed rebound in M&A-related issuance, with falling rates expected to provide the necessary catalyst as the year progressed.

However, the week of April 7 was the first in Europe since April 2022 to record no new launches across both bonds and loans, according to LCD. Though Germany-based facilities management group Apleona — which is largely tariff-proof — successfully closed its €2.35 billion-equivalent euro and sterling buyout loan on April 10 against the backdrop of exceptionally difficult conditions, other underwritten deals in the calendar will likely provide a tougher test.

The largest situation waiting in the wings in Europe is the $2.5 billion term loan and $2 billion secured bridge supporting Walgreens Boots Alliance's international business as part of Sycamore Partners' take-private of the global pharmacy chain. Syndication here is not expected until the second half of the year.

Market players, however, are generally optimistic in the face of market jitters, Indeed, they cite the drought of new M&A paper in recent years, which has not only left banks low on underwriting risk (and all-important fees), but has also heightened demand from the buyside to source assets and stay invested.

Changing landscape
Looking at where clearing terms for buyout loans stood before April’s financial market meltdown, companies funding buyouts via a term loan B paid an average yield-to-maturity of 6.72% (on a three-month rolling basis) in March — slightly higher than the February reading of 6.64%.

By way of comparison, investors commanded a yield as high as 9.68% in April 2023, while back in April 2021, companies funded buyouts via newly issued loans at just 3.96%.

With the cost of funding now hovering close to the cheapest level seen for nearly three years, leverage multiples are moving off recent lows. In the trailing 12-month reading, average leverage for buyout deals was 4.87x in March, up from a 12-year low of 4.58x at the end of 2024.

Still, companies remain hamstrung in terms of the amount they can leverage up, considering that average leverage for buyout deals in 2021 was at a record high of 6.48x.



Financing costs though remain a way off the record lows seen in pre-rate hike times, and companies therefore continue to rely on cheaper, first-lien debt. Leverage raised this past year from second-lien loans or junior debt is near negligible, with first-lien loans accounting for 99% of the debt financing package. In 2022, first-lien debt accounted for a smaller 84% on this measure.

Historically, higher debt funding costs have also curbed excess risk-taking, with the share of deals leveraged at 6x or more falling to 15% in the LTM period. At the height of the pre-GFC market in 2007, 51% of deals cleared with leverage of 6x or more.



Equity infusions
In an effort to lower leverage expense, private equity firms have offered up relatively higher equity infusions. In 2024, equity contributions hit 49%, up from 44% in 2023 and 42% in 2022. The need to prop-up deals via equity has begun to ease, with average contributions in LCD's rolling 12-month calculation falling to 45% in March.



In addition to shifting the debt funding mix, the knock-on effect of higher all-in yields has been a reduction in purchase price multiples paid by sponsor companies. LCD’s data shows this metric for deals financed in the broadly syndicated loan (BSL) market was below 10x in the trailing 12-month calculation. This is the lowest level since 2015.

In terms of transaction activity, primary corporate buyouts staged a comeback in Q1, rising to 43% of deals by count (albeit among a relatively small observation pool), from 28% in full-year 2024. Helping to free up capital for redeployment among private equity firms, secondary transactions in 2024 indicated increased movement between PE firms by accounting for 56% of transactions, versus 46% in 2023.



Dividend payments
With markets becoming more accommodating to opportunistic issuance, sponsors also sought to eke out returns via debt-funded dividend payments, LCD data shows. The €4.52 billion of institutional and pro rata loans issued in Q1 to fund dividend recapitalizations marked the busiest start for this purpose in four years.

More broadly, private equity firms remained active, even with M&A deal flow still proving more elusive than hoped. PE shops issued €33.6 billion of leveraged loans in the first quarter, up from €21.2 billion in Q4 2024 and €22.4 billion in Q1 2024. This was the busiest first quarter for sponsored companies in the loan market since Q1 2007.



This time, however, buyouts made up only 18% of volume by use of proceeds, with refinancings, recaps and other M&A issuance accounting for the bulk of activity at 82% in the year to date. By comparison, buyouts accounted for 56% of sponsor-related debt issuance in 2022.

Stefano Madrigali/Getty Images

Learn about our editorial standards.